These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7477159)

  • 21. [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
    Leclercq V; Lacaille S; Delpierre S; Karoubi E; Legrain S
    Rev Med Interne; 2005 Oct; 26(10):835-6. PubMed ID: 16023268
    [No Abstract]   [Full Text] [Related]  

  • 22. Maintenance digoxin in elderly patients.
    Dall JL
    Br Med J; 1970 Jun; 2(5711):705-6. PubMed ID: 5429654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
    Wettengel R; Vetter N; Waardenburg FA
    J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
    Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
    Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration.
    Friedman HS; Chen TS
    Am Heart J; 1982 Jul; 104(1):72-6. PubMed ID: 6178280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alprazolam-related digoxin toxicity.
    Tollefson G; Lesar T; Grothe D; Garvey M
    Am J Psychiatry; 1984 Dec; 141(12):1612-3. PubMed ID: 6150651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between digoxin-induced cardiac arrhythmias and serum-digoxin levels (author's transl)].
    Hennersdorf G; Mariss P; Biermann S; Haindl H; Lichtlen P
    Dtsch Med Wochenschr; 1977 Mar; 102(11):381-4. PubMed ID: 66122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinidine-induced digoxin toxicity after discontinuing digoxin in a patient with renal failure.
    Nigam SK; Burton ME; Vasko MR
    Clin Pharm; 1984; 3(6):662-4. PubMed ID: 6509882
    [No Abstract]   [Full Text] [Related]  

  • 33. [Digoxin level as a limited drug toxicity indicator in the assessment of post-digitalis arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A
    Wiad Lek; 1994; 47(21-24):808-12. PubMed ID: 8999691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between itraconazole and digoxin.
    McClean KL; Sheehan GJ
    Clin Infect Dis; 1994 Feb; 18(2):259-60. PubMed ID: 8161643
    [No Abstract]   [Full Text] [Related]  

  • 35. Congestive heart failure and toxic digoxin levels: role of cholestyramine.
    Roberge RJ; Sorensen T
    Vet Hum Toxicol; 2000 Jun; 42(3):172-3. PubMed ID: 10839325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telithromycin-induced digoxin toxicity and electrocardiographic changes.
    Nenciu LM; Laberge P; Thirion DJ
    Pharmacotherapy; 2006 Jun; 26(6):872-6. PubMed ID: 16716140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case series of hospitalized patients with elevated digoxin levels.
    Marik PE; Fromm L
    Am J Med; 1998 Aug; 105(2):110-5. PubMed ID: 9727817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of plasma digoxin measurements.
    Cristodorescu R; Deutsch G; Drăgan S
    Med Interne; 1989; 27(1):25-32. PubMed ID: 2749155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil-digoxin interaction.
    Zatuchni J
    Am Heart J; 1984 Aug; 108(2):412-3. PubMed ID: 6380256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.